The least frequently added (≤1%) concomitant psychotropic medications in the population of patients with noncomorbid ADHD were AMPH LA, guanfacine IR, bupropion, MPH LA, TCAs, clonidine XR, SNRIs, and TAPs (Figure 3B). Here, AMPH is linked to attention deficit-hyperactivity disorder.